Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.1 USD | +0.84% | -0.44% | +4.55% |
03:43pm | AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders | MT |
09/05 | Medincell: share price rises on resumption of trading | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.55% | 284B | |
+28.95% | 684B | |
+30.34% | 568B | |
-3.86% | 361B | |
+17.80% | 329B | |
+16.06% | 240B | |
+9.33% | 208B | |
-6.83% | 200B | |
+7.80% | 166B | |
-0.61% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Truist Adjusts Price Target on AbbVie to $195 From $180, Maintains Buy Rating